Navigation Links
New discovery could dramatically reduce leishmaniasis treatment doses and side effects
Date:11/5/2013

The Amphotericin B (AmB) is the main active ingredient in the most effective drug used to treat leishmaniasis, a disease which in the Western world mainly affects dogs, but in developing countries affects over 12 million people, with more than 70,000 deaths per year. The cost of treating humans with AmB surpasses $5,000 per patient, the treatment is extensive (2-hour sessions every day during 21 days), and the side effects are frequent and many times patients must be hospitalised.

Researchers from the University of Miami, Florida and the Universitat Autnoma de Barcelona have developed a method which allows to drastically reduce the drug dose, since it improves its efficacy 83%, multiplies by 10 the capacity of the drug to attack cell infected by the parasite which provokes the disease, and significantly reduces the toxicity of the parasite. The method has been successfully tested on mice models of leishmaniasis.

The complex compound acts through the action of the PDD nanoparticle, a substance measuring some 10 nanometres in diameter which is fit into the active principle, Amphotericin B, and guides it selectively to the cells harbouring the parasite. Scientists observed how, while the usual complete dose of the drug requires over 12 days to reduce the skin lesions caused by the disease, one dose of the complex compound with only 17% of the complete dose of the drug improves skin lesions in two or three days. Moreover, the complex compound acts as a therapeutic vaccine which activates the immune system against the reservoir cells hosting the parasite.

The PDD substance has been used in previous trials with people with the aim of improving the response of their immune system to other diseases. Now there is a need for clinical trials with humans in order to verify its safety as an adjuvant in the treatment of leishmaniasis. If its safety in humans is confirmed, it will also reduce the cost of the treatment drastically, and this is a k
'/>"/>

Contact: Jordi Alberola
jordi.alberola@uab.cat
34-935-811-532
Universitat Autonoma de Barcelona
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Biosimulation Market (For Drug Discovery & Development) Worth $1.2 Billion by 2017 - New Report by MarketsandMarkets
2. Discovery could lead to anti-clotting drugs with less risk of bleeding
3. International group finds 11 new Alzheimers genes to target for drug discovery
4. Biosimulation Market (Drug Discovery & Development) Worth $1.2 Billion by 2017 - New Report by MarketsandMarkets
5. New Case Management Order in New Jersey DePuy ASR Recall Litigation Extends Discovery to June 2014, More than 650 Metal Hip Lawsuits Filed in Consolidated Proceeding
6. The Producers of the In View Series Announce Upcoming Airing on the Discovery Channel
7. Ethicon Transvaginal Mesh Lawsuits Move Forward, With Scheduling of Discovery Conferences in Federal Vaginal Mesh Litigation, Bernstein Liebhard LLP Reports
8. LDM Global eDiscovery Professional, Jennifer Holt, is Awarded CEDS Certification
9. Cancer/Tumor Profiling Market (Personalized Medicine, Biomarker Discovery, Prognosis, Research) Worth $35.03 Billion by 2018 – New Report by MarketsandMarkets
10. Propofol discovery may help lead to development of new anaesthetics
11. American Brain Tumor Association Seeks Inventive Ideas for Research Discovery Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... AttorneyOne.com, a recognized authority on law, update ... FDA on Ibuprofen and Oxcarbazepine Tablets . , ... Ibuprofen and one lot of Oxcarbazepine Tablets, by American Health ... Oxcarbazepine is used for the treatment of certain types of ... for the recall is that Lot #142588, Expiration Date, 01/2016 ...
(Date:7/25/2014)... July 25, 2014 Ticket Down ... Inter Milan tickets in Berkeley at California Memorial Stadium. ... new fans of football, the organizers of the 2014 Guinness ... club teams to North America. With teams representing La Liga, ... will bring some of the best football players from around ...
(Date:7/25/2014)... AZ (PRWEB) July 25, 2014 ... , a Nuanced Media client and the nation’s ... and dental employee handbooks, announced their partnership with ... TransAct is a registered ISO/MSP of Chase Paymentech ... the transaction processing industry. Companies that are members ...
(Date:7/25/2014)... Hastings and Hastings, a personal injury ... to personal injury claims, announces free initial consultations. Hastings ... services for those that have been injured as a ... Free initial consultation services gives clients’ greater flexibility in ... personal injury claim . It also offers clients the ...
(Date:7/25/2014)... workers, especially men, may be at higher risk for type ... new study suggests. Also at special risk are shift ... moving around at various times of the day. The ... Alan Manevitz, a clinical psychiatrist at Lenox Hill Hospital in ... shifts disrupts many key body chemicals, creating a ripple effect ...
Breaking Medicine News(10 mins):Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 3Health News:Nuanced Media Client, CEDR HR Solutions, Partners with TransAct to Serve Medical, Dental, and Eye Care Professionals 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 3Health News:Study Links Shift Work to Risk for Type 2 Diabetes 2Health News:Study Links Shift Work to Risk for Type 2 Diabetes 3
... 15, 2010)Michael C. Soulen, M.D., FSIR, delivered the ... Society of Interventional Radiology,s 35th Annual Scientific Meeting ... SIR Foundation, acknowledges an interventional radiologist,s extraordinary contributions ... distinguished career achievements in interventional radiology. Soulen, ...
... tissue, or the layer of fat around the heart, can ... coronary artery calcium scoring, according to research by cardiologists at ... of fat around the heart can be measured by X-ray ... may be used as a ,gate keeper, in that it ...
... An Indiana University School of Medicine study provides a ... activity after periods of abstinence, information key to dealing ... school girls and beyond. While there has been ... experiences, the IU study is among the first to ...
... (March 15, 2010) New research findings published in the ... of Surgeons indicate that some breast cancers continue to ... through mammographic screening. Patients who presented with palpable tumors ... examination had larger tumors and were at a more ...
... ... Chicago on March 19. , ... Lafayette, CA (PRWEB) March 15, 2010 -- How has the recession affected baby boomer consumers? ... businesses need to know to effectively engage boomers using traditional and new media, online communities, ...
... ... Kevin Nini will be leading a new reconstructive breast surgery program at Hunterdon Regional Cancer ... and other breast enhancement procedures. , ... (PRWEB) March 15, 2010 -- Plastic Surgery Arts of New Jersey (PSANJ) is proud ...
Cached Medicine News:Health News:Society of Interventional Radiology Foundation honors Michael C. Soulen as Dotter lecturer 2Health News:Society of Interventional Radiology Foundation honors Michael C. Soulen as Dotter lecturer 3Health News:Society of Interventional Radiology Foundation honors Michael C. Soulen as Dotter lecturer 4Health News:Imaging fat layer around heart can help predict disease 2Health News:Why do sexually experienced girls resume sexual activity after abstinence? 2Health News:Palpable breast cancers are more common in women not undergoing annual mammography 2Health News:Palpable breast cancers are more common in women not undergoing annual mammography 3Health News:2010 What's Next Boomer Business Summit Provides the Blueprint for Successfully Marketing to Baby Boomers 2Health News:2010 What's Next Boomer Business Summit Provides the Blueprint for Successfully Marketing to Baby Boomers 3Health News:Dr. Kevin Nini to Lead Reconstructive Breast Surgery Program at Hunterdon Regional Cancer Center 2Health News:Dr. Kevin Nini to Lead Reconstructive Breast Surgery Program at Hunterdon Regional Cancer Center 3
(Date:7/25/2014)... 2014 Cardinal Health will today name three ... of its prestigious Independent Pharmacy Best Practices Competition, during ... the nation,s largest gatherings of independent pharmacists. ... from Ohio , Tennessee ... were selected for implementing exceptionally creative methods that demonstrate ...
(Date:7/25/2014)... 2014  Solanbridge Group Inc (OTC: SLNX) is pleased ... in Buzznbrewz.com and the Letter of Intent issued on ... executed Purchase Agreement. Charles R. Shirley ... to have Mr. David Pecoraro and Buzznbrewz.com ... the private sector and developed a tremendous network of ...
(Date:7/25/2014)... N.Y. and MEXICO CITY , July 25, 2014 ... that PLM, a Latin American healthcare sciences publisher, launched ... medical information on conditions such as cancer and heart ... access the most up-to-date information to deliver better patient ... is growing rapidly, with many relying on smartphones and ...
Breaking Medicine Technology:Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 2Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 3Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 4Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 5Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 6Solanbridge Group Inc Announces Acquisition of Buzznbrewz.com 2Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 2Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 3Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 4
... Cambridge Temperature Concepts (CTC), the company behind the ... I Award by the Wireless-Life Sciences Alliance (WLSA) ... . DuoFertility uses wireless technology to predict when ovulation will ... possible chance of conceiving naturally. News of this win follows ...
... Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ... in China based on the number of directly operated ... first quarter ended March 31, 2011. ... Revenue increased by 9.0% to RMB618.1 million (US$94.4 ...
Cached Medicine Technology:Cambridge Temperature Concepts Wins Prestigious Award From the Wireless-Life Sciences Alliance for Fertility Monitor DuoFertility 2Cambridge Temperature Concepts Wins Prestigious Award From the Wireless-Life Sciences Alliance for Fertility Monitor DuoFertility 3Cambridge Temperature Concepts Wins Prestigious Award From the Wireless-Life Sciences Alliance for Fertility Monitor DuoFertility 4China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 2China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 3China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 4China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 5China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 6China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 7China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 8China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 9
Body Suit w/Bra above knee...
Gynecomastia Vest...
Male Compression Vest, Front Closure...
Female Mini-VEST, Front Closure, X-Firm...
Medicine Products: